Myeloma in Scar Tissue - An Underreported Phenomenon or an Emerging Entity in the Novel Agents' Era? A Single Center Series

Publisher： Karger

E-ISSN： 1421-9662|132|1|39-44

ISSN： 0001-5792

Source： Acta Haematologica, Vol.132, Iss.1, 2014-01, pp. : 39-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis

By  

Acta Haematologica, Vol. 137, Iss. 3, 2017-04 ,pp. : 163-172

Karger

Access to resources Recommend Favorite

Extramedullary disease in multiple myeloma in the era of novel agents

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 763-765

John Wiley & Sons Inc

Access to resources Recommend Favorite

A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 145-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

By  

Acta Haematologica, Vol. 132, Iss. 2, 2014-03 ,pp. : 211-219

Karger

Access to resources Recommend Favorite

Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide–bortezomib combinations

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 843-850

John Wiley & Sons Inc

Access to resources Recommend Favorite